Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Merck consumer sales dip: Merck Consumer Care experienced a drop in first-quarter sales compared to a year ago, when, as a unit of Schering-Plough, it benefited from the launch of Claritin Liqui-Gels (1"The Tan Sheet" April 27, 2009). In the first three months of 2010, Whitehouse Station, N.J.-based Merck reported consumer sales of $379 million, down 1.3 percent. Claritin OTC sales sank 26.2 percent to $110 million in the quarter, Merck said May 4. The firm's overall quarterly results reflected effects and costs attributable to the Schering merger; net sales rose 112.1 percent to $11.42 billion, but net income dropped 77.3 percent to $330.2 million. Diluted earnings per share were off 86.6 percent to 9 cents. Merck said it expects in 2012 to begin realizing $3.5 billion in annual synergy savings
You may also be interested in...
In Brief
European trade group touts tradition for herb claims substantiation; Vitacost exits manufacturing; Perrigo launches generic Delsym; Austrian firm offers paper-free blister lid; more news In Brief.
Vitacost.com Turns To Vitamin Shoppe Founder To Right Ship
Vitacost.com CEO Ira Kerker steps down and Jeffrey Horowitz takes the post after logistics challenges and a proxy fight shook up the company's board of directors
Vitacost.com Turns To Vitamin Shoppe Founder To Right Ship
Vitacost.com CEO Ira Kerker steps down and Jeffrey Horowitz takes the post after logistics challenges and a proxy fight shook up the company's board of directors